Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: nutraceuticals
investor
nutraceuticals
medicine
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
March 18, 2026
press release
nutraceuticals
medicine
video
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026
press release
nutraceuticals
medicine
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA Symposium
March 12, 2026
press release
investor
nutraceuticals
science
eXoZymes advancing commercial readiness with profound production metrics on initial NCT pilot run
January 29, 2026
investor
nutraceuticals
medicine
press clippings
International Business Times: AI meets enzymes - eXoZymes enables high-yield production of compounds previously impossible to make
December 17, 2025
press release
investor
nutraceuticals
medicine
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversion
December 11, 2025
nutraceuticals
medicine
press clippings
Vanity Fair: Inside NCTx - How A Rare Plant-Derived Molecule Is Turning Fat Into A Boost Of Energy
November 26, 2025
investor
nutraceuticals
medicine
press clippings
LA Weekly: The Enzyme Frontier - eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma
November 20, 2025
heltzen
investor
nutraceuticals
medicine
press clippings
video
'The Upside' interview: Michael Heltzen & Lou Basenese
November 18, 2025
press release
investor
nutraceuticals
video
science
eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity
July 29, 2025
Previous page
Page 1 of 2
Next page